Pharmaceutical The Indian subsidiary of US healthcare giant Johnson & Johnson today announced a new partnership with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR), to unlock the potential of Indian science and help accelerate the discovery of innovative new tuberculosis (TB) treatments. 16 August 2017